Hannah Y Wen Selected Research

Fibrocystic Breast Disease (Chronic Cystic Mastitis)

1/2021	Morphologic and immunohistochemical features of carcinoma involving microglandular adenosis of the breast following neoadjuvant chemotherapy.
1/2017	Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hannah Y Wen Research Topics

Disease

22	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2015
21	Neoplasms (Cancer) 01/2022 - 01/2015
6	Triple Negative Breast Neoplasms 12/2021 - 01/2016
4	Carcinoma (Carcinomatosis) 01/2021 - 07/2019
3	Disease Progression 07/2021 - 01/2019
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 07/2019 - 08/2017
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 12/2020
2	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 01/2021 - 01/2017
2	Papillary Carcinoma 01/2020 - 08/2017
2	Acinar Cell Carcinoma 12/2019 - 01/2017
2	Pathologic Complete Response 08/2019 - 09/2017
2	Lymphatic Metastasis 01/2018 - 01/2016
1	Brain Neoplasms (Brain Tumor) 03/2022
1	Fibroadenoma 02/2022
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022
1	Small Cell Carcinoma 10/2021
1	Rhabdoid Tumor (Rhabdoid Tumors) 10/2021
1	Bites and Stings (Sting) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Infections 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Intraductal Papilloma 01/2020
1	Fatigue 01/2020
1	Adenomyoepithelioma 01/2018
1	Lobular Carcinoma 09/2017
1	Adenocarcinoma 08/2017
1	Carcinogenesis 03/2016

Drug/Important Bio-Agent (IBA)

14	Estrogen ReceptorsIBA 01/2022 - 01/2016
6	human ERBB2 proteinIBA 03/2021 - 03/2016
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2015
3	B7-H1 AntigenIBA 01/2022 - 01/2020
3	Hormones (Hormone)IBA 01/2022 - 01/2020
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 01/2019
3	RNA (Ribonucleic Acid)IBA 12/2019 - 03/2016
2	ChromatinIBA 10/2021 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2017
2	Monoclonal AntibodiesIBA 01/2021 - 01/2020
2	MucinsIBA 07/2019 - 01/2019
1	Trastuzumab (Herceptin)FDA Link 03/2022
1	pertuzumabIBA 03/2022
1	Mediator ComplexIBA 02/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2022
1	EpitopesIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 10/2021
1	atezolizumabIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Dihydrotachysterol (AT 10)IBA 12/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	AntibodiesIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Checkpoint Kinase 2IBA 06/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	AntigensIBA 01/2019
1	LigandsIBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2018
1	Codon (Codons)IBA 01/2018
1	erucylphosphocholineIBA 08/2017
1	Complex MixturesIBA 03/2017
1	ParaffinIBA 03/2017
1	Formaldehyde (Formol)FDA Link 03/2017
1	Tamoxifen FDA LinkGeneric 01/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 03/2016
1	Tetracycline (Achromycin)FDA LinkGeneric 03/2016
1	Phenobarbital (Luminal)FDA Link 01/2016

Therapy/Procedure

7	Therapeutics 01/2022 - 03/2016
6	Neoadjuvant Therapy 03/2022 - 09/2017
5	Drug Therapy (Chemotherapy) 01/2020 - 08/2017
4	Immunotherapy 01/2022 - 01/2021
2	Segmental Mastectomy (Lumpectomy) 07/2021 - 01/2021
2	Radiotherapy 01/2020 - 01/2020
1	Adjuvant Chemotherapy 01/2017